Chatila, Walid K. http://orcid.org/0000-0001-5474-218X
Walch, Henry http://orcid.org/0000-0003-1188-350X
Hechtman, Jaclyn F.
Moyer, Sydney M. http://orcid.org/0000-0002-2911-4058
Sgambati, Valeria http://orcid.org/0000-0002-8964-646X
Faleck, David M.
Srivastava, Amitabh http://orcid.org/0000-0001-5165-8142
Tang, Laura
Benhamida, Jamal http://orcid.org/0000-0001-5542-9857
Ismailgeci, Dorina http://orcid.org/0000-0002-1177-8905
Campos, Carl
Wu, Fan http://orcid.org/0000-0002-3960-320X
Chang, Qing
Vakiani, Efsevia http://orcid.org/0000-0003-0227-3523
de Stanchina, Elisa
Weiser, Martin R.
Widmar, Maria
Yantiss, Rhonda K. http://orcid.org/0000-0001-6068-4617
Shah, Manish A. http://orcid.org/0000-0002-6913-9655
Bass, Adam J. http://orcid.org/0000-0002-8193-4758
Stadler, Zsofia K.
Katz, Lior H.
Mellinghoff, Ingo K. http://orcid.org/0000-0002-4347-8149
Sethi, Nilay S. http://orcid.org/0000-0002-3748-7559
Schultz, Nikolaus http://orcid.org/0000-0002-0131-4904
Ganesh, Karuna http://orcid.org/0000-0002-4948-1082
Kelsen, David http://orcid.org/0000-0001-6139-438X
Yaeger, Rona http://orcid.org/0000-0002-7233-5454
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P30 CA08748)
Starr Foundation (I11-0040)
Article History
Received: 30 June 2022
Accepted: 13 December 2022
First Online: 7 January 2023
Competing interests
: N.S.: Advisory role for Astrin Biosciences. Z.K.S.: Immediate family member serves as a consultant in Ophthalmology for Alcon, Adverum, Gyroscope Therapeutics Limited, Neurogene, and RegenexBio, outside the submitted work. I.K.M.: Research funding from General Electric, Agios, Amgen, and Lilly; advisory roles with Agios, Debiopharm Group, Puma Biotechnology, and Voyager Therapeutics; and honoraria from Roche for a presentation. R.Y.: Research funding from Boehringer Ingelheim, Mirati Therapeutics, Pfizer, and Daiichi Sankyo; advisory roles with Mirati Therapeutics, Natera, Array BioPharma/Pfizer, and Zai Lab. All other authors declare no competing interests.